Targets for 2020:

- 95% coverage for hepatitis B vaccination with 4 doses established in the National Vaccination Calendar;

- 95% coverage for the first dose of hepatitis B vaccine given to newborns in the first 24 hours after birth;

- 75% coverage for testing the pregnant women for hepatitis B and C and 95% coverage for the post-exposure prophylaxis with HBIG in newborns from infected mothers in the first 12 hours after birth, associated with the first dose of hepatitis B vaccine;

- all donated blood to be tested by PCR for HBV and HCV; - 50% injections to be given using safety-engineered injection devices;

- to assure the continuity of the harm reduction programmes for PWIDs (to distribute at least 200 syringes/PWID/year);

- at least 40% opiod-dependent PWIDs to receive OST;

- 95% coverage for hepatitis B vaccination in uninfected PWIDs;

- at least 25% of persons living with chronic infections with HBV,HDV and HCV to be diagnosed and informed about their disease;

- at least 75% of persons detected with HVB and HCV infections and eligible for treatment to be enrolled in antiviral treatment;

- to obtain viral suppression for at least 70% of the patients being in long-term treatment for hepatitis B;

- to diagnose at least 75% of the patients being in advanced stages of disease with HBV and HCV (cirrhosis or hepatocellular carcinoma);

- to cure at least 95% of the patients with chronic hepatitis C enrolled in treatment.